The company
SI-BONE, Inc.
SIBN · Nasdaq
SIBN stood above a rising 150-day average in 18 of the last 52 weekly readings, including each of the last 8 weeks. It is 20.4% above that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−7 points in four weeks); Health Care: 26% (−10 points in four weeks).
Statistics
- Rotation
- In trend
- Weeks in an uptrend
- 8 in a row
- Industry in uptrend
- 27% -7 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $19.0M
- Officials’ trades on record
- 0
- Institutions holding
- 159 (-8)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 18 of 52 weeks.
Medical Devices: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Laura FrancisChief Executive Officer | sold | 38,006at $20.05 | 12 Oct 2026filed 14 Oct 2026 |
| Anshul MaheshwariChief Op & Financial Officer | sold | 1,731at $19.50 | 5 Oct 2026filed 6 Oct 2026 |
| Michael A. PisetskySVP, Ops & Adm/Chief Legal Ofr | sold | 1,300at $18.20 | 2 Oct 2026filed 6 Oct 2026 |
| Michael A. PisetskySVP, Ops & Adm/Chief Legal Ofr | sold | 1,799at $18.14 | 2 Oct 2026filed 6 Oct 2026 |
| Michael A. PisetskySVP, Ops & Adm/Chief Legal Ofr | sold | 34at $18.14 | 2 Oct 2026filed 6 Oct 2026 |
| Anshul MaheshwariChief Op & Financial Officer | sold | 1,560at $18.17 | 2 Oct 2026filed 6 Oct 2026 |
| Anshul MaheshwariChief Op & Financial Officer | sold | 1,758at $18.19 | 2 Oct 2026filed 6 Oct 2026 |
| Jeffrey W. DunnDirector | sold | 20,000at $18.47 | 1 Oct 2026filed 5 Oct 2026 |
| Jeffrey W. DunnDirector | sold | 18,633at $18.91 | 1 Sep 2026filed 3 Sep 2026 |
| Jeffrey W. DunnDirector | sold | 1,367at $18.91 | 1 Sep 2026filed 3 Sep 2026 |
| Laura FrancisChief Executive Officer | sold | 25,972at $20.12 | 24 Aug 2026filed 26 Aug 2026 |
| Anshul MaheshwariChief Op & Financial Officer | sold | 11,636at $20.11 | 24 Aug 2026filed 26 Aug 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| First Light Asset Management, LLCadded · filed 14 Aug 2026 | 8,127,985$132.6M | +2,774,795+51.8% |
| BlackRock, Inc.added · filed 7 Aug 2026 | 3,676,259$60.0M | +247,718+7.2% |
| CADIAN CAPITAL MANAGEMENT, LPadded · filed 14 Aug 2026 | 3,347,574$54.6M | +1,460,102+77.4% |
| AMERICAN CENTURY COMPANIES INCadded · filed 12 Aug 2026 | 2,510,963$41.0M | +1,898+0.1% |
| BROWN ADVISORY INCreduced · filed 14 Aug 2026 | 2,077,134$33.9M | -45,198−2.1% |
| Granahan Investment Management, LLCadded · filed 14 Aug 2026 | 1,931,182$31.5M | +192,085+11.0% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 1,838,499$30.0M | +74,186+4.2% |
| Impax Asset Management Group plcunchanged · filed 11 Aug 2026 | 1,425,010$23.3M | 00.0% |
| GILDER GAGNON HOWE & CO LLCadded · filed 14 Aug 2026 | 1,253,042$20.4M | +204,526+19.5% |
| PARADIGM CAPITAL MANAGEMENT INCadded · filed 13 Aug 2026 | 1,233,200$20.1M | +106,700+9.5% |
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.